Free Trial

Enhabit (EHAB) Projected to Post Quarterly Earnings on Wednesday

Enhabit logo with Medical background

Enhabit (NYSE:EHAB - Get Free Report) is expected to be announcing its Q1 2025 earnings results after the market closes on Wednesday, May 7th. Analysts expect the company to announce earnings of $0.07 per share and revenue of $266.11 million for the quarter.

Enhabit Stock Down 0.5 %

Shares of EHAB traded down $0.04 on Monday, reaching $8.01. The company's stock had a trading volume of 114,373 shares, compared to its average volume of 480,431. Enhabit has a twelve month low of $6.85 and a twelve month high of $10.70. The stock has a market capitalization of $405.60 million, a PE ratio of -3.45 and a beta of 1.61. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a fifty day moving average of $8.28 and a 200-day moving average of $8.03.

Analysts Set New Price Targets

Separately, Jefferies Financial Group restated a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.

Get Our Latest Research Report on Enhabit

Enhabit Company Profile

(Get Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Read More

Earnings History for Enhabit (NYSE:EHAB)

Should You Invest $1,000 in Enhabit Right Now?

Before you consider Enhabit, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.

While Enhabit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines